A data-fueled framework for sponsors and CROs in navigating this shifting terrain.
Samir Shah
Advertisement
President, Strategic Solutions, ICON
Articles by Samir Shah
Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?
Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Advertisement
Latest Updated Articles
Anticipating Near-Term Structural Change in the Outsourcing LandscapePublished: December 22nd 2023 | Updated:
The Strategic Emergence of Site Networks in Clinical ResearchPublished: October 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
Using AI and Tokenized Data to Match Patients to Protocols
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
